HHS To Test Three New Models to Lower Drug Prices
Expanding on President Biden’s Executive Order, “Lowering Prescription Drug Costs for Americans,” the Department of Health and Human Services (HHS) announced a plan to test three new models to lower drug costs in the U.S. The models include $2 generic drugs, better access to cell and gene therapies, and developing new payment models for drugs granted accelerated approval.
It's free! Log in now to read
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115